Martingale Asset Management’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-25,304
| Closed | -$894K | – | 952 |
|
|
2017
Q1 | $894K | Sell |
25,304
-25,407
| -50% | -$898K | 0.01% | 739 |
|
|
2016
Q4 | $635K | Sell |
50,711
-468
| -0.9% | -$5.86K | 0.01% | 797 |
|
|
2016
Q3 | $709K | Buy |
51,179
+29,365
| +135% | +$407K | 0.01% | 753 |
|
|
2016
Q2 | $216K | Buy |
+21,814
| New | +$216K | ﹤0.01% | 798 |
|